The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Tesaro/GSK
Travel, Accommodations, Expenses - Roche
Final results from the KEYNOTE-100 trial of pembrolizumab in patients with advanced recurrent ovarian cancer.
 
Ursula A. Matulonis
Honoraria - Advaxis
Consulting or Advisory Role - Immunogen; Merck; Novartis
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Roni Shapira
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - Clovis Oncology; MSD; VBL Therapeutics
 
Alessandro Santin
Consulting or Advisory Role - Merck; Tesaro
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Merck (Inst); Puma Biotechnology (Inst); R-Pharm (Inst); Tesaro (Inst)
 
Alla Sergeevna Lisyanskaya
Honoraria - AstraZeneca (Inst); INCURON (Inst); MSD (Inst); REGENERON (Inst); Roche (Inst)
Research Funding - AstraZeneca; INCURON; MSD; Regeneron; Roche
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Carrick Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Medical University of Vienna (Inst); Millennium (Inst); MSD Belgium (Inst); Octimet (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Francesco Raspagliesi
No Relationships to Disclose
 
Gabe S. Sonke
Consulting or Advisory Role - Novartis (Inst)
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Michael Birrer
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novocure; Pfizer; PharmaMar; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Antonio González-Martín
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Genmab; GlaxoSmithKline/Tesaro; Merck; MSD; Novartis; Oncoinvent; Pfizer; Roche
Speakers' Bureau - AstraZeneca; GlaxoSmithKline/Tesaro; Roche
Research Funding - GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Tesaro
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; Immunogen; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Clovis Oncology (Inst); Eisai (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
P. B. Ottevanger
No Relationships to Disclose
 
Vilius Rudaitis
Travel, Accommodations, Expenses - MSD Oncology; Roche
 
Haiyan Wu
Employment - MSD
Stock and Other Ownership Interests - Merck Sharp & Dohme (I)
Travel, Accommodations, Expenses - MSD RD China
 
Stephen Michael Keefe
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Karen Stein
Employment - Merck
Stock and Other Ownership Interests - Merck; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Merck
 
Jonathan A. Ledermann
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - Artios; AstraZeneca/MedImmune; Clovis Oncology; Cristal Therapeutics; Eisai; Merck; Pfizer; Seagen; Tesaro
Speakers' Bureau - Clovis Oncology; Pfizer; Tesaro/GSK
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Clovis Oncology
Other Relationship - Regeneron